Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Artery Infusion Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06519578
What this trial is testing

Prospective Real-World Study of HAIC With Raltitrexed or 5-Fluorouracil for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
RenJi Hospital 1,115
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06375317
What this trial is testing

HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy Failure

Who this might be right for
HCC - Hepatocellular Carcinoma
Yehua Shen 42
Testing effectiveness (Phase 2)UnknownNCT06375486
What this trial is testing

Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）.

Who this might be right for
Hepatocellular Carcinoma Non-resectableHepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Early research (Phase 1)Study completedNCT00008294
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06904183
What this trial is testing

Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 320
Testing effectiveness (Phase 2)UnknownNCT06335927
What this trial is testing

HAIC Combined With Cadonilimab and Regorafenib as 2nd-line Treatment for ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fudan University 45
Not applicableLooking for participantsNCT07070076
What this trial is testing

A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Li Qiang 286
Large-scale testing (Phase 3)Active Not RecruitingNCT05198609
What this trial is testing

Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 214
Testing effectiveness (Phase 2)Ended earlyNCT06370663
What this trial is testing

First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shandong Cancer Hospital and Institute 1
Testing effectiveness (Phase 2)Study completedNCT05024513
What this trial is testing

Biliary Drainage Plus HAIC in Locally Advanced pCCA

Who this might be right for
Perihilar Cholangiocarcinoma
Peking University 127
Large-scale testing (Phase 3)Looking for participantsNCT07594340
What this trial is testing

HAIC vs. TACE Combined With Sintilimab and Bevacizumab for Intermediate HCC (Beyond Up-To-Seven)

Who this might be right for
Hepatocellular Carcinoma
Binkui Li 300
Testing effectiveness (Phase 2)Looking for participantsNCT06741020
What this trial is testing

Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhejiang Cancer Hospital 10
Large-scale testing (Phase 3)Looking for participantsNCT06904170
What this trial is testing

Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
UNICANCER 196
Not applicableStudy completedNCT05489692
What this trial is testing

HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Sun Yat-sen University 43
Testing effectiveness (Phase 2)Study completedNCT03009461
What this trial is testing

Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis

Who this might be right for
HepatoCellular CarcinomaPortal Vein Thrombosis
Peking University 64
Testing effectiveness (Phase 2)Looking for participantsNCT07636798
What this trial is testing

Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
West China Hospital 20
Testing effectiveness (Phase 2)UnknownNCT05617430
What this trial is testing

Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 43
Testing effectiveness (Phase 2)Looking for participantsNCT07569679
What this trial is testing

Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for Unresectable Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Air Force Military Medical University, China 124
Large-scale testing (Phase 3)Looking for participantsNCT06796803
What this trial is testing

Camrelizumab Combined With Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC)

Who this might be right for
Potentially Resectable Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 398
Not applicableStudy completedNCT06631326
What this trial is testing

HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)

Who this might be right for
HCC - Hepatocellular CarcinomaHepatic Arterial Infusion ChemotherapyBCLC Stage C Hepatocellular Carcinoma+2 more
First Hospital of China Medical University 244
Next Page